U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

Showing 11 - 11 of 11 results

GI-6207

MORE DETAILS

FIJ3OLQ3N8

structurally diverse
Status:
Possibly Marketed Outside US
Source:
BLA125563
(2018)
Source URL:
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3a9f3411-5272-451c-bf3f-7f44ea1d18df
First approved in 2018
Source:
BLA125563
Source URL:
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3a9f3411-5272-451c-bf3f-7f44ea1d18df
Class:
STRUCTURALLY DIVERSE

Showing 11 - 11 of 11 results

NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966